Depressants for Mineral Ore Flotation

US2018071752A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2018071752-A1
Application numberUS-201515538471-A
CountryUS
Kind codeA1
Filing dateDec 18, 2015
Priority dateDec 30, 2014
Publication dateMar 15, 2018
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Depressants comprising a polymer comprising: a) recurring units of one or more acrylamide monomers; b) recurring units of one or more monomers selected from hydroxyalkyl alkylacrylate, allyloxyalkyldiol, allyloxyethanol, trimethylolpropane allyl ether, and 2-hydroxy ethyl acrylate; and optionally, c) recurring units of one or more acrylic acid monomers are provided. Also disclosed are processes for enriching a desired mineral from an ore comprising the desired mineral and gangue, wherein the process comprises carrying out a flotation process in the presence of one or more of the depressants.

First claim

Opening claim text (preview).

1 . A depressant comprising a polymer comprising a) recurring units of one or more acrylamide monomers; b) recurring units of one or more monomers selected from hydroxyalkyl alkylacrylate, allyloxyalkyldiol, allyloxyethanol, trimethylolpropane allyl ether, and 2-hydroxy ethyl acrylate; and optionally, c) recurring units of one or more acrylic acid monomers. 2 . The depressant of claim 1 , wherein the polymer comprises recurring units of one or more hydroxyalkyl alkylacrylate monomers. 3 . The depressant of claim 1 , wherein the recurring units in the polymer comprise about 70% to about 95% of the one or more acrylamide monomers and about 5% to about 30% of the one or more monomers selected from hydroxyalkyl alkylacrylate, allyloxyalkyldiol, allyloxyethanol, trimethylolpropane allyl ether, and 2-hydroxy ethyl acrylate. 4 . The depressant of claim 2 , wherein the one or more hydroxyalkyl alkylacrylate monomers comprises a hydroxyalkyl moiety and an alkylacrylate moiety. 5 . The depressant of claim 4 , wherein the alkyl of the hydroxyalkyl moiety is selected from a C 1-6 linear or branched alkyl and wherein the alkyl of the alkylacrylate moiety is selected from a C 1-6 linear or branched alkyl. 6 . The depressant of claim 2 , wherein the one or more hydroxyalkyl alkylacrylate monomers comprises hydroxyethyl methylacrylate. 7 . The depressant of claim 1 , wherein the recurring units in the polymer comprise about 5% to about 92% of the one or more acrylamide monomers, about 3% to about 65% of the one or more acrylic acid monomers, and about 5% to about 30% of the one or more monomers selected from hydroxyalkyl alkylacrylate, allyloxyalkyldiol, allyloxyethanol, trimethylolpropane allyl ether, and 2-hydroxy ethyl acrylate. 8 . A composition comprising: one or more depressant according to claim 1 ; and a solvent. 9 . The composition of claim 7 , wherein the solvent is water. 10 . A process for enriching a desired mineral from an ore comprising the desired mineral and gangue, wherein the process comprises carrying out a flotation process in the presence of one or more depressants according to claim 1 . 11 . The process of claim 9 , wherein the desired mineral is an iron-containing mineral. 12 . The process of claim 9 , wherein the gangue comprises oxides of silica, silicates or siliceous materials. 13 . The process of claim 9 , wherein the flotation process is a reverse cationic flotation process. 14 . The process of claim 9 , wherein the one or more depressants is added in the form of a composition comprising the depressant and a solvent. 15 . The process of claim 13 , wherein the solvent is water. 16 . The process of claim 9 , wherein the improves the grade of iron from iron ore such that the grade of the recovered iron is at least about 61%. 17 . The process of claim 9 , wherein the process reduces the amount of silica in the iron ore to less than about 10%.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2018071752A1 cover?
Depressants comprising a polymer comprising: a) recurring units of one or more acrylamide monomers; b) recurring units of one or more monomers selected from hydroxyalkyl alkylacrylate, allyloxyalkyldiol, allyloxyethanol, trimethylolpropane allyl ether, and 2-hydroxy ethyl acrylate; and optionally, c) recurring units of one or more acrylic acid monomers are provided. Also disclosed are processes…
Who is the assignee on this patent?
Kemira Oyj
What technology area does this patent fall under?
Primary CPC classification B03D1/016. Mapped technology areas include Operations & Transport.
When was this patent published?
Publication date Thu Mar 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).